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Pontemporary Stent Treatment of Coronary Bifurcations
oannis Iakovou, MD, Lei Ge, MD, Antonio Colombo, MD
ilan, Italy
Treatment of coronary bifurcation lesions represents a challenging area in interventional
cardiology. The introduction of drug-eluting stents (DES) reduced restenosis in the main
branch (MB). However, restenosis at the ostium of the side branch (SB) remains a problem.
Although stenting the MB with provisional SB stenting seems to be the prevailing approach,
in the era of DES various two-stent techniques emerged (crush) or were re-introduced (V or
simultaneous kissing stents, crush, T, culottes, Y, skirt) to allow stenting in the SB when
needed. This review describes in detail various techniques used for implantation of two stents
by intention to treat. (J Am Coll Cardiol 2005;46:1446–55) © 2005 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.080College of Cardiology Foundation
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iecent advances in percutaneous coronary interventions and
ately the introduction of drug-eluting stents (DES) have
ed to the dramatic increase in the number of patients
reated percutaneously (1–5). Bifurcation lesions are one of
he complex lesion subsets that are now being confronted
ore frequently. Bifurcation interventions, when compared
ith nonbifurcation interventions, have a lower rate of
rocedural success and a higher rate of restenosis (6–8).
arious techniques with the use of one or two stents have
een developed to optimize the treatment of this subset of
esions (6–15). Paradoxically, although stenting of individ-
al lesions has been shown to be superior to balloon
ngioplasty, stenting of both branches seems to offer no
dvantage over stenting of the main branch (MB) alone (8).
he recent introduction of DES has resulted in a lower
vent rate and reduction of MB restenosis in comparison
ith historical controls (16). However, side branch (SB)
stial restenosis remains a problem.
NATOMICAL CONSIDERATIONS
ifurcations have been classified previously according to the
ngulation between the main and the SB and according to
he location of the plaque burden. Regarding the former,
he bifurcations are classified as Y-shaped lesions, when the
ngulation is 70° and access to the SB is usually easy but
laque shifting is more pronounced, and T-shaped lesions,
hen the angulation is 70° and access to the SB is usually
ore difficult but plaque shifting is often minimal. This
ngulation is modified after wiring both branches. Regard-
ng plaque distribution, there have been four major attempts
o categorize bifurcations, which chronologically are the
uke (Fig. 1A) (17), the Sanborn (Fig. 1B) (18), the Safian
Fig. 1C) (19), and the Lefevre (Fig. 1D) classifications
20). The above attempts are very commendable but suffer
he limitations of coronary angiography (different plaque
istribution and extent of disease when evaluated by intra-
ascular ultrasound), and they do not take into account what
appens to the SB on dilatation of the MB. Therefore, each
From the Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy.o
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ccepted May 23, 2005.esion must be approached therapeutically in the context of
ts own anatomy.
ES AND BIFURCATIONS
ntil now, there have been only two randomized studies
nd some observational reports that specifically addressed
he issue of bifurcational lesion treatment with DES
16,21–23). The recently published sirolimus-eluting stent
SES) bifurcational study emphasized the persistent limita-
ions related to the routine stenting of the SB (16). In
nother study, stenting for the MB and balloon dilatation
or the SB was compared with stenting for both branches.
imilar to the previous study, there were no statistically
ignificant differences between the two strategies (22).
HROMBOTIC ISSUES AFTER
ES IMPLANTATION IN BIFURCATIONS
athologic studies have suggested that arterial branch points
re foci of low shear and low flow velocity and are sites
redisposed to the development of atherosclerotic plaque,
hrombus, and inflammation (24–26). The two or even
hree layers of struts (with crush) of DES apposed to the
essel wall initially raised concerns about possible increased
hrombogenicity. Furthermore, delayed endothelialization
ssociated with DES may extend the risk of thrombosis
eyond 30 days (27). In the SES bifurcational study, the rate
f stent thrombosis was 3.5%. Recently we reported in a
rospective observational cohort study a rate of 3.6% of
umulative stent thrombosis at nine-month follow-up after
ES implantation in bifurcations (28).
NE OR TWO STENTS?
s the SB large enough (2.5 mm in the U.S., and 2.25 mm
here smaller DES stents are available) with a sufficient
erritory of distribution to justify stent implantation? This
nitial question must be answered before going into further
etail. There are also rare circumstances in which the SB is
mportant and cannot be wired. In this situation the
perator must consider alternative solutions, such as bypass
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October 18, 2005:1446–55 Coronary Bifurcation Treatmenturgery if the bifurcation in question is the left main or the
eft anterior descending vessel and a large diagonal vessel.
In general, we try not to stent the SB, but if needed, we
lan an effective strategy for stenting both branches. The
ecision to use one or two stents, or sometimes even three
in case of a trifurcation), should be made as early as
ossible. An appropriate and timely taken decision will
ffect the results, save time, lower costs, and lower the risk
f complications. If we decide to use one stent (at the MB),
here is almost always the possibility of placing a second
tent on the SB in case the result is not optimal or adequate.
his condition is defined as provisional stenting.
ELECTION OF GUIDING CATHETER
he selection of the size (6-F, 7-F, or 8-F) of the guiding
atheter occurs after deciding whether or not to stent the
B. Treatment of bifurcations frequently requires simulta-
eous insertion of two balloons or two stents; therefore,
ome specific considerations regarding the selection of an
ppropriate guiding catheter are important. With the cur-
ently available low-profile balloons (e.g., Maverick, Boston
cientific, Natick, Massachusetts), it is possible to insert
wo balloons inside a large-lumen 6-F guiding catheter. If
wo stents are needed, some limitations should be under-
tood. The two stents can only be inserted one after the
ther, not simultaneously, in a 6-F guiding catheter. The
tandard crush and the V or simultaneous kissing stents
echnique cannot be performed unless a guiding catheter of
t least 7-F, with an internal lumen diameter of 0.081 inches
2.06 mm) for the Taxus stent (Boston Scientific) or 8-F
ith an internal lumen diameter of 0.088 inches (2.2 mm)
or the Cypher (Cordis, Johnson and Johnson, Warren,
ew Jersey) stent, is used. A 6-F guiding catheter can be
sed if the operator performs a provisional stenting tech-
ique with a second stent (for the SB) that is advanced after
ositioning the first stent in the MB. Techniques such as
he T, the reverse crush, and the step crush (see later for a
escription of each technique) can all be used with a 6-F
uiding catheter. The modified T technique requires at least
7-F guiding catheter, and the culottes, Y, and skirt
echniques require at least 8-F guiding catheters.
NE STENT BY INTENTION TO TREAT
he most common approach in the treatment of bifurca-
ions is stenting only the MB.
The first step is to decide whether a wire is needed in the
B. We propose that a wire is needed in the following
Abbreviations and Acronyms
DES drug-eluting stent
MB  main branch
SB  side branch
SES  sirolimus-eluting stentircumstances: 1) the operator is undecided regarding (hether or not to place a wire, 2) the SB has a narrowing at
ts ostium, 3) the MB has severe stenosis with a large plaque
urden and the SB originates with an angle of45°, or 4) the
stium of the SB deteriorates after pre-dilatation of the MB.
The second step is to decide whether pre-dilation of the
B and/or the SB is required.
The third step is to place a stent in the MB. The stent
hould be deployed at low pressure (8 atm) so as not to
amage the trapped wire in the SB or to deteriorate the ostium
f a SB without a wire across the stent struts of the MB.
The fourth step is to place a wire into the SB; this
rocedure can be performed with the wire trapped behind
he stent serving as a marker. Regarding the wire of choice
or re-entering the SB, we prefer first to use a floppy wire
uch as the Balance Universal (Guidant, Temecula, Califor-
ia); if not successful, we would then try an intermediate
ire or a Rinato wire (Asahi Intecc [Thailand] Co. Ltd.,
athumthani, Thailand), and in rare cases we may use a
ydrophilic wire such as the Pilot 50 or 150 (Guidant).
The fifth step, after having rewired the SB, is to post-
ilate the MB stent at high pressure. We may use the same
alloon for stent delivery, or if we are concerned about distal
r proximal dissections, we will use a short balloon, usually
oncompliant. If we think that the stent may be underde-
loyed, especially in its proximal part, it is important to
erform sequential step inflations with the short balloon.
In the sixth step, the results are evaluated. At the level of
he MB, the results should be optimal, or higher-pressure
ilatation should be performed. If the result at the level of
he SB is satisfactory, the procedure is considered complete.
The seventh step is performed only if the operator
onsiders the result at the SB not satisfactory. In this case,
ilatation of the SB and kissing balloon inflation (usually at
atm) between the main and the SB is performed. If the
esult is acceptable after kissing balloon inflation, the
rocedure is considered complete.
The eighth step occurs only if the result at the SB is
nsatisfactory. At this point the operator can still decide to
top because the SB is not ideal for stenting because of
ifficulty in positioning a stent, size, distal runoff, complex-
ty of the procedure, and so on. If the operator thinks that
he result at the level of the SB needs to be improved, then
tenting is performed according to the reverse crush or T
pproach.
mpossible SB access. Even if rare, there are some circum-
tances in which due to the location of the plaque in the MB
nd/or the angulation of the SB, the wire cannot be
dvanced at the SB. A further high-pressure dilatation of
he stent at the MB may better open the stent struts and
acilitate the access toward the SB. Although rare, after
ttempting different types of wires with all types of curves
nd techniques, it may still be impossible to advance a wire
n the SB. At this point few options are available: 1) stop the
rocedure because the risk of losing the SB will be too high,
onsidering also the size and distribution of the branch
typically an angulated circumflex artery when stenting the
1448 Iakovou et al. JACC Vol. 46, No. 8, 2005
Coronary Bifurcation Treatment October 18, 2005:1446–55Figure 1. Classifications of bifurcations according to plaque burden: Duke (A) (17), Sanborn (B), Safian (C), and Lefevre (D) classifications.
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October 18, 2005:1446–55 Coronary Bifurcation Treatmentistal bifurcation of an unprotected left main); 2) perform
irectional atherectomy on the MB with the intent of
emoving the plaque that prevents entry toward the SB; and
) dilate the MB with a balloon with the rationale that the
laque modification to a favorable plaque shift will facilitate
ccess toward the SB.
solated ostial lesions involving the MB or the SB. With
solated ostial lesions, it is important to accurately place a
tent to cover the lesion entirely without protruding into the
ther branch. Some operators use intravascular ultrasound
o facilitate appropriate stent placement. In our practice, we
pproach these lesions as follows:
SOLATED OSTIAL LESION OF MB. There are two ap-
roaches for treating these lesions: 1) placement of a stent at
he ostium of the MB with a balloon protecting the SB and
ith inflation of the SB balloon and kissing balloon only if
laque shift occurs, and 2) placement of a stent in the MB
overing the origin of the SB and then wiring the SB and
erforming kissing balloon inflation in case the ostium of
he SB deteriorates.
Some operators, especially if the ostial lesion involves the
eft anterior descending vessel, may perform directional
therectomy with or without stenting at the ostium of the
eft anterior descending vessel.
SOLATED OSTIAL LESIONS OF SB. The most common ap-
roach to treating these lesions is to place a stent at the
stium of the SB, frequently with a balloon placed but not
nflated in the MB. If after stent placement there is
Figure 2. The V stenting technique.eterioration of the MB at the site of the bifurcation, thealloon in the MB is inflated, protecting the stent by a
imultaneous inflation of the stent delivery balloon (T with
stent and a balloon).
WO STENTS BY INTENTION TO TREAT
number of two-stent techniques are available, with
arious levels of complexity and indications: the V, the
imultaneous kissing stents, crush and its variations (reverse
nd step), T and its variation (modified), culottes, Y, and
kirt. These techniques are described in detail in the
ollowing text.
HE V AND THE SIMULTANEOUS
ISSING STENTS TECHNIQUES
he V technique consists of the delivery and implantation
f two stents together. One stent is advanced in the SB, the
ther in the MB, and the two stents touch each other,
orming a proximal carina (Fig. 2) (29,30). When the carina
xtends a considerable length (usually 5 mm or more) into
he main vessel, this technique is called simultaneous kissing
tents (Fig. 3) (31). The type of lesion we consider most
uitable for this technique is a very proximal lesion such as
bifurcation lesion located at the left main stem with a left
ain artery that is short or free of disease. Ideally the angle
etween the two branches should be less than 90°. The V
echnique is also suitable for other bifurcations provided the
ortion of the vessel proximal to the bifurcation is free of
isease and there is no need to deploy a stent more
roximally.
dvantages. The main advantage of these techniques is
hat the access to either of the two branches is never lost. InFigure 3. The simultaneous kissing stents technique.
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Coronary Bifurcation Treatment October 18, 2005:1446–55ddition, when a final kissing inflation is performed, there is
o need to re-cross any stent.
isadvantages. It is intuitive how problematic may be the
eed to position a stent proximal to the double barrel. There
s an inevitable bias toward one of the two branches and the
igh likelihood of leaving a gap. If there is a need to place
stent at the proximal segment of a vessel treated with V
tenting, there are two options: 1) a stent is placed proxi-
ally, leaving a small gap between the kissing stents and the
roximal stent, and 2) the kissing stent technique is con-
erted into a crush technique, with the stent in the MB
ompressing the other stent (one arm of the V) in the SB.
wire will then cross the struts into the SB, and a balloon
ill be inflated toward the SB. After wire removal from the
B, the proximal stent will be advanced toward the MB. In
his case we are left with a short segment of the MB
roximal to the bifurcation, which has four layers of struts.
ecause of the complexity of this maneuver, it is clear how
mportant it is to select lesions for the V technique in which
here is a very low risk of performing proximal stenting.
HE CRUSH TECHNIQUE
he crush technique (13) was introduced at the time of
ES introduction and is described schematically in Figure
. Two stents are placed in the MB and the SB, with the
ormer more proximal than the latter. The stent of the SB
s deployed, and its balloon and wire are removed. The stent
ubsequently deployed in the MB flattens the protrudingaFigure 4. The crush technique.ells of the SB stent, hence the name crushing or crush
echnique. Wire re-crossing and dilatation of the SB with a
alloon of a diameter at least equal to that of the stent (32),
nd then final kissing balloon inflation, is recommended
21,23). The implementation of final kissing balloon infla-
ion was done to allow better strut contact against the
stium of the SB and therefore better drug delivery (21,32).
he crush technique therefore became a sort of simplified
ulottes technique. The positive aspect is that whenever
estenosis occurs, this narrowing is very focal (5 mm in
ength) and most of the time is not associated with symp-
oms or ischemia. An important element to keep in mind
hen planning to perform the crush technique is that the
wo available DES will reach different maximal openings of
heir cells (21,33). The maximal cell diameter will be 3.0
m for the Cypher stent and 3.7 mm for the Taxus stent.
his information should be kept in mind when the SB has
diameter 3.0 mm.
dvantages. The main advantage of the crush technique is
hat the immediate patency of both branches is assured.
his is important when the SB is functionally important or
ifficult to be wired. In addition, this technique provides
xcellent coverage of the ostium of the SB.
isadvantages. The main disadvantage is that the perfor-
ance of the final kissing balloon inflation makes the
rocedure more laborious because of the need to re-cross
ultiple struts with a wire and a balloon.
HE REVERSE CRUSH
he main indication for performing the reverse crush is to
llow an opportunity for provisional SB stenting. A stent is
eployed in the MB, and balloon dilatation with final
issing inflation toward the SB is performed. It is assumed
hat the result at the ostium or at the proximal segment of
he SB is suboptimal for deploying a stent at this site. A
econd stent is advanced into the SB and left in position
ithout being deployed. Then a balloon sized according to
he diameter of the MB is positioned at the level of the
ifurcation, making sure to stay inside the stent previously
eployed in the MB. The stent in the SB is retracted about
to 3 mm into the MB and deployed, the deploying balloon
s removed, and an angiogram is obtained to verify that a
ood result is present at the SB (no further distal stent in the
B is needed). If this is the case, the wire from the SB is
emoved and the balloon in the MB is inflated at high
ressure (12 atm or more). The other steps are similar to the
nes described for the crush technique and involve re-
rossing into the SB, performing SB dilatation, and final
issing balloon inflation.
dvantages. The main advantages of the reverse crush
echnique are that the immediate patency of both branches
s assured and that the technique can be performed using a
-F guiding catheter.
isadvantages. This technique has the same disadvantagess the standard crush and is even more laborious.
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October 18, 2005:1446–55 Coronary Bifurcation TreatmentHE STEP CRUSH TECHNIQUE
he only difference from the standard crush technique is
hat each stent is advanced and deployed separately. First, a
tent is advanced in the SB protruding into the MB a few
illimeters. A balloon is then advanced in the MB over the
ifurcation. Then the stent in the SB is deployed, the balloon
s removed, and an angiogram is performed: if the result is
dequate, the wire is also removed. The MB balloon is then
nflated to crush the protruding SB stent and is removed.
ubsequently, a stent is advanced in the main branch and is
eployed (usually at 12 atm or more).The next steps are
imilar to those of the crush technique and involve re-
rossing into the SB, performing SB stent dilatation, and
nal kissing balloon dilatation.
dvantages. The main reason to use this technique is to
erform the crush technique with a 6-F guiding catheter.
perators who perform the radial approach may be partic-
larly interested in this technique.
isadvantages. This technique has the same disadvantages
s the standard crush technique.
TECHNIQUE
he classic T technique consists of positioning a stent first
t the ostium of the SB, being careful to avoid stent
rotrusion into the MB (Fig. 5). Some operators leave a
alloon in the MB to help to further locate the MB. After
Figure 5. The T stenting technique.eployment of the stent and removal of the balloon and theire from the SB, a second stent is advanced in the MB. A
ire is then re-advanced into the SB, and final kissing
alloon inflation is performed. Modified T stenting is a
ariation performed by simultaneously positioning stents at
he SB and the MB (Fig. 6). The SB stent is deployed first,
nd then after wire and balloon removal from the SB, the
B stent is deployed.
dvantages. This technique is less laborious than the crush
echnique. Unlike the V technique, it can be used for the
overage of lesions located proximal to the bifurcation.
isadvantages. In almost all cases, this technique will lead
o incomplete coverage of the ostium of the SB. Currently
his technique has been discontinued in our practice, and
here are two reasons to perform the T technique: 1) to
lace a stent at the ostium of a SB after placement of a stent
n the MB because the result at the SB ostium was evaluated
s unsatisfactory (provisional SB stenting), and 2) to per-
orm stenting at the ostium of the SB when there is isolated
B ostial stenosis.
HE CULOTTES TECHNIQUE
he culottes technique uses two stents and leads to full
overage of the bifurcation at the expense of an excess of
etal covering of the proximal end (7) (Fig. 7). Both
ranches are pre-dilated. First a stent is deployed across the
ost angulated branch, usually the SB. The non-stented
ranch is then rewired through the struts of the stent and
ilated. A second stent is advanced and expanded into the
on-stented branch, usually the MB. Finally, kissing bal-
oon inflation is performed.Figure 6. The modified T stenting technique.
A
b
o
D
c
c
d
t
T
T
w
s
i
b
s
a
s
p
s
t
A
d
w
D
t
a
u
p
c
d
p
r
p
a
n
1452 Iakovou et al. JACC Vol. 46, No. 8, 2005
Coronary Bifurcation Treatment October 18, 2005:1446–55dvantages. This technique is suitable for all angles of
ifurcations and provides near-perfect coverage of the SB
stium.
isadvantages. Like the crush technique, it leads to a high
oncentration of metal with a double-stent layer at the
arina and in the proximal part of the bifurcation. The main
isadvantage of the technique is that rewiring both branches
hrough the stent struts can be difficult and time consuming.
HE Y AND THE SKIRT TECHNIQUES
he Y technique has a particular historical value because it
as one of the first bifurcation stenting techniques demon-
trated in a live case course (34). This technique involves an
nitial pre-dilatation, followed by stent deployment in each
ranch (11) (Fig. 8). If the results are not adequate, a third
tent may also be deployed in the MB. To effectively try to
pproximate the proximal stent to the already-deployed
tents, it is necessary to modify the stent delivery device by
lacing one stent over two balloons (see description of the
kirt technique in Fig. 9). With this technique, wire access
o both branches is not lost.
dvantages. This technique is a last resort for treating very
emanding bifurcations in which there is a need to maintain
ire access to both branches.
isadvantages. The major limitation of this approach is
he need to modify the delivery system of the proximal stent
nd to manually crimp the stent on two balloons. When
sing a DES, this approach may lead to alteration of the
olymer. In addition to this issue, it is not always feasible to
Figure 7. The culottes stenting technique.losely approximate the proximal stent to the two moreistal ones. For these reasons, when there is a need to
erform the Y technique, a more practical approach is to
emove the wire from the SB and advance and deploy a
roximal stent in the MB, trying to approximate this stent
s close as possible to the already-deployed stents at the
ewly formed carina.
Figure 8. The Y stenting technique.Figure 9. The skirt technique.
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October 18, 2005:1446–55 Coronary Bifurcation TreatmentESION PREPARATION
laque removal before stent implantation, using directional
therectomy in noncalcified lesions and rotational atherec-
omy in calcified lesions, has been attractive. However, the
ncouraging results of many single-center experiences (35)
ave not been reproduced in the context of randomized
tudies (36,37).
ole of atherectomy. Analysis of the Coronary Angio-
lasty Versus Excisional Atherectomy Trial (CAVEAT)-I
ndicated the ability to achieve a larger post-procedure
umen in the main vessels in bifurcation lesions treated with
irectional atherectomy as opposed to angioplasty. This
esult was obtained with an increased risk of SB occlusion,
ith an increase in small non–Q-wave myocardial infarc-
ion, and with no difference in the six-month rate of
estenosis (38). In the time of the Stenting after Optimal
esion Debulking (SOLD) registry (39), bifurcational le-
ions were included with very encouraging results, leading to
he launch of the Atherectomy and MULTILINK Stenting
mproves Gain and Outcome trial (AMIGO) (40). How-
ver, this study failed to support the original findings and
ypothesis, even in the subgroup of lesions involving a
ifurcation. The main problem of directional atherectomy is
hat the technique is very operator-dependent and the
mount of tissue removal varies depending on the commit-
ent of the operator to performing extensive debulking. In
ddition, except for the very recent introduction of the
ilverhawk device (Fox Hollow Technologies, Redwood
ity, California), no further developments in the devices
vailable were made for a long time period.
In spite of these concerns and the lack of scientific
vidence supporting the advantage of plaque debulking in
ifurcation lesions, our experience in this setting has been
avorable and we still occasionally combine atherectomy and
ES when the anatomical setting is appropriate, such as a
eft main stenosis with a large plaque burden shown by
ntravascular ultrasound and plaque characteristics suitable
or removal with current directional atherectomy devices.
ole of rotational atherectomy. As opposed to directional
oronary atherectomy, which can be considered an optional
rocedure, the use of rotational atherectomy could be, in
ome lesions, the only procedure to permit lesion dilatation
nd hence stent delivery.
In most catheterization laboratories, the use of this
rocedure is 5% of all interventions. Early reports stated
n advantage in facilitating stent delivery and expansion,
ith a suggestion for clinical benefit when used in lesions
hat demanded the use of this technology (41). The Stent-
ng Post Rotational Atherectomy (SPORT) randomized
tudy, using rotational atherectomy and stenting, failed to
upport any advantage of this technology over standard
tenting (37). Our interpretation is that a niche technology
annot show its advantage when used outside the specific
rea of very calcified lesions, which were excluded from the
PORT trial. Most of the time, rotablation is performed only on the MB, but occasionally (very rarely) also or only
n the SB. We think that especially with the use of DES,
esion preparation with compliance change for a very calci-
ed lesion can substantially facilitate stent delivery and
ymmetrical stent expansion with more homogeneous drug
elivery.
ole of cutting balloon. A number of single-center studies
42–44) reported the beneficial combination of stenting
receded by cutting balloon dilatation. In bifurcation le-
ions, in which there is a large fibrotic plaque at the ostium
f the SB, the use of the cutting balloon as a pre-dilatation
trategy before stenting seems reasonable. The Restenosis
eduction by Cutting balloon Evaluation trial (REDUCE
II) evaluated the role of cutting balloon pre-dilatation
efore stenting versus standard balloon pre-dilatation in a
ariety of lesions. This trial reported a lower restenosis rate
hen lesions were pre-dilated with the cutting balloon.
Currently, we suggest the use of the cutting balloon in
oderately calcific and fibrotic lesions, especially ones that
nvolve the origin of the SB. In heavily calcified lesions,
nstead of using a larger burr, the cutting balloon could be
sed after small-burr rotablation with the goal of minimiz-
ng any distal embolization. Symmetric stent expansion,
voidance of SB recoil, and stent compression are all
ttractive hypotheses that need proper evaluation.
SSOCIATED PHARMACOLOGIC TREATMENT
hen performing bifurcational stenting, we do not usually
hange our protocol of peri-procedural heparin administra-
ion (100 U/kg without and 70 U/kg with concomitant
lective glycoprotein IIb/IIIa inhibitors). Use of glycopro-
ein IIb/IIIa inhibitors is reserved to thrombus-containing
esions, patients with unstable angina, acute myocardial
nfarction, and when long stents are implanted on both
ranches. These agents are sometimes administered when
he final result at the SB seems suboptimal and for when
arious clinical or anatomical reasons the operator thinks it
s not necessary to implant another stent.
We carefully consider peri-procedural preparation with
hienopyridines, and when in doubt we administer a
00-mg loading dose of clopidogrel in the catheterization
aboratory.
The duration of combined thienopyridine and aspirin
reatment after stent implantation varies according to the
ength of the stent implanted, the type of stent used, and the
linical conditions of the patient (acute coronary syndrome
t the time of stenting or diabetes mellitus).
UTURE DIRECTIONS AND CONCLUSIONS
hen treating bifurcation lesions, we must pay attention to
hoosing the right guiding catheter size (should be large
nough to accommodate two balloons or two stents when
eeded a priori or when likely to be used). A wire should be
laced in the SB especially if there is disease at the ostium
r with a problematic take-ff. The general consensus is to
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s not severely diseased, implantation of a stent in the MB
nd provisional stenting in the SB is the preferred
trategy. Implantation of two stents as the initial ap-
roach is appropriate when both branches are signifi-
antly diseased (diameter stenosis 50%) and suitable for
tenting. Final kissing balloon inflation should be per-
ormed in these cases.
The ongoing randomized trial Coronary bifurcations:
pplication of the Crushing Technique Using Sirolimus-
luting stents (CACTUS) comparing a provisional SB
trategy with the crush technique using Cypher stents may
elp to better answer the approach of one versus two stents
n true bifurcation lesions. Although dedicated stents are
eing developed, their clinical use in the format of DES is
till very limited. However, these devices may have poten-
ially important applications in proximal large bifurcations
nd in the left main trunk.
Despite all of the unanswered questions and some per-
isting problems, we cannot deny two major achievements
n bifurcational stenting since the introduction of DES: 1)
ingle-digit restenosis rates on the MB, and 2) focal
estenosis at the SB, very frequently clinically silent.
onsidering how much has been done may help us to be
ore optimistic toward looking at what still needs to be
one.
eprint requests and correspondence: Dr. Antonio Colombo,
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